News | April 08, 2025
NATCO Pharma updates on legal proceedings on Risdiplam launch in India
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
The portfolio includes branded injectable cephalosporines for infectious diseases
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The inspection has concluded with four observations
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Amifampridine Tablets, 10 mg are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older.
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
